drugset / Trial / NCT05692869
A Study of Continuous Blood Pressure Monitoring in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study in healthy participants is to find out whether the traditional ambulatory blood pressure monitor (ABPM) and newer wearable devices (EmbracePlus smartwatch device, Biobeat chest patch device, and Aktiia wrist device) will accurately pick up changes in blood pressure caused by 2 different medications (propranolol and pseudoephedrine). The study will last about 29 days excluding the screening period of 28 days.
Timeline
- Start
- 2023-01-31
- Primary completion
- 2023-04-04
- Completion
- 2023-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propranolol | Small molecule | — | Oral |
| Subject | Pseudoephedrine | Small molecule | — | Oral |
Indications
No indication recorded.